Edwards Lifesciences (NYSE:EW) Releases Q4 2024 Earnings Guidance
Edwards Lifesciences (NYSE:EW – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 0.530-0.570 for the period, compared to the consensus EPS estimate of 0.620. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 […]
24 Oct 22:28 · The Markets Daily